The global CAR T-cell therapy market is witnessing substantial growth, driven by increasing occurrence of cancer and positive regulatory approvals. Major players in the market are participating in development to expand their product portfolio and meet the growing need for effective cancer treatments. Furthermore, advancements in CAR T-cell therapy